Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
166.41 USD
1.06%
Market Closed
Updated:
Apr 20, 2024
Abbvie Inc
Other Non-Cash Items
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Other Non-Cash Items Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Non-Cash Items
$9.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
32%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Non-Cash Items
$3B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
7%
|
CAGR 10-Years
23%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Non-Cash Items
$-560m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Non-Cash Items
$538.6m
|
CAGR 3-Years
37%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-5%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Non-Cash Items
$1.2B
|
CAGR 3-Years
57%
|
CAGR 5-Years
21%
|
CAGR 10-Years
17%
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Other Non-Cash Items
$376.5m
|
CAGR 3-Years
61%
|
CAGR 5-Years
79%
|
CAGR 10-Years
28%
|
See Also
What is Abbvie Inc's Other Non-Cash Items?
Other Non-Cash Items
9.3B
USD
9.3B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Non-Cash Items amounts to 9.3B USD.
What is Abbvie Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
32%
32%
Over the last year, the Other Non-Cash Items growth was 37%. The average annual Other Non-Cash Items growth rates for Abbvie Inc have been 2% over the past three years , 6% over the past five years , and 32% over the past ten years .
You don't have any saved screeners yet
